1. Introduction
Obstruction of a main cerebral artery reduces the blood flow to the brain and causes cerebral ischemia, as occurs in a stroke. As a consequence, limited glucose and oxygen supply lead to neuronal damage. Initially, injury results from inhibition of oxidative phosphorylation that decreases adenosine triphosphate (ATP) production that, among other changes, provokes inactivation of the N
+/K
+-ATPase and an excessive release of glutamate. The over-activation of glutamate receptors induces calcium accumulation at the mitochondria level, favoring free radical production by the mitochondrial respiratory chain [
1]. The generation of oxidative stress is a crucial point for the induction of neuronal injury observed after cerebral ischemia; therefore, treatment with antioxidants has shown a protective effect through different mechanisms of action in experimental models [
2]. However, the characterization of other antioxidant compounds is still required since results obtained with the current ones indicate these are not suitable yet.
In the past years, several extracts of plants have appeared on the market as antioxidants, and the physiological activities of the natural components have been identified. Interestingly, many food sources potentially have beneficial effects in counteracting cardiovascular complications, such as coronary heart disease and stroke [
3]. The antioxidant capacity of some of these mixtures showed comparable or even higher activities than synthetic antioxidants [
4,
5]. Moreover, synthetic antioxidants frequently have toxic and other undesirable side effects. Thus, the characterization of innocuous, safer, and low-cost effective antioxidants from natural sources, such as vegetables and plants, is still necessary.
In this line, resveratrol (RSV), a stilbene found in grapes (among many other plant products), has been widely recognized for its ability to modulate the dynamics of the cellular redox-status in vitro and in vivo in experimental models of ischemia [
2,
6]. The beneficial effects of RSV in ischemia include the suppression of production of superoxide anion (O
2•
−), providing neuroprotection through regulation of pathways sensitive to oxidative stress, such as AMPK/SIRT and PI3K/AKT/mTOR [
7]. Recently, it was reported that in cerebral ischemia and in a model of oxygen and glucose deprivation, RSV modulates autophagy, the process that removes and recycles damaged cellular components through AMPK activation [
8]. Because RSV is in the spotlight due to its effects on the human body suffering from disease and its low toxicity [
9,
10], we used it as a reference in the neuroprotective effect against ischemia-induced damage in vitro and in vivo.
Several species of medicinal plants have neuroprotective activities for the CNS. These effects are mainly associated with their composition in antioxidant compounds such as flavonoids and terpenoids. Plants of the family Lamiaceae, Annonaceae, and Geraniaceae have been traditionally used to treat central nervous system pathological conditions in several models, including cerebral ischemia [
11,
12,
13]. Therefore, we include plants of these families in our study.
Annonaceae is a large family of plants consisting of about 2300 to 2500 species, and more than 130 genera distributed mainly in tropical and sub-tropical regions. The presence of alkaloids, flavonoids, and acetogenins found in leaves, bark, seeds, and fruit is a chemical distinctive of this family. Concerning the species of Annonaceae, those from the genus
Annona comprise approximately 175 species of trees and shrubs. In Mexico, the genus
Annona contains around 60 species in 12 genera, with the largest number found in forests. Among these, the most cultivated are
Annona cherimola, A. muricata, A. reticulata, A. diversifolia, A. purpurea, and
A. squamosa. Furthermore, economically, this genus is the most appreciated of the Annonaceae family due to its edible fruits, nutritional value, and medicinal properties [
14]. Annonaceae inhibit production of O
2•
− production [
15]. O
2•
− is the primary and more damaging reactive oxygen specie produced during cerebral ischemia and recovery of blood flow (reperfusion) [
16]. The extract obtained from
A. diversifolia also reduced the severity of behavioral and electroencephalographic seizures, supporting its effect on the central nervous system [
17].
Geraniaceae is a family comprising about 11 genera and more than 730 species widely distributed in subtropical, tropical, and temperate areas worldwide. In the case of the genus
Geranium, it constitutes around 300 species. Some of these species are high multi-harvest species, with high value as aromatic cultivated herbs for their essential oils, which are widely used in the cosmetic industry and to flavor foods [
18]. In Mexico, the genus
Geranium grows along the dry stream banks and grassy meadows of the pine–oak forests, and of this genus the species
Geranium niveum and
G. mexicanum are used as medicinal plants or ornamentals [
19]. Several reports indicate the antiprotozoal activity of these plants as their bioactivity due to compounds such as flavonoids [
20].
G. mexicanum exhibits a high content of cathechin [
21], an active compound that shows neuroprotective effects against cerebral ischemia [
22]. Additionally, cathechin protect against cell apoptosis in myocardial ischemia and reperfusion injury, supporting its beneficial effects by modulating pathways sensitive to oxidative stress [
23].
The Lamiaceae family includes nearly 1000 species organized in four sections: Salvia, Leonia, Clarea, and Calosphace [
24].
Salvia is the principal genus in the mint family; these plants are shrubs, herbaceous perennials, and annuals. Many
Salvia species are used in cooking as herbal tea and for food flavoring. They are also used in cosmetics, perfumery, and pharmaceutical industries around the world [
25]. Importantly, many species of Lamiaceae have been used traditionally for the treatment of a variety of neurodegenerative disorders and some have shown protective properties in cerebral ischemia, reducing lipid peroxidation, restoring the glutathione content, and attenuating motor impairment [
12]. In Mexico the
Salvia species are included in the Mirto complex; it includes
Salvia polystachya and
S. amarissima. The bioactive clerodane diterpenes are abundant in both species [
26]. Clerodanes can be used to activate opioid receptors and protect against cerebral ischemia [
27].
Our main objective was to characterize the antioxidant capability of extracts obtained from various plants from Annonaceae, Lamiaceae, and Geraniaceae families. We examined the hydroxyl radical (OH•), peroxyl radical (ROO•), and O2•− scavenging capacity of nine extracts using either the leaves or aerial parts of the plants. Besides, we tested the efficiency of the extracts to prevent the neuronal death induced by excitotoxicity, and their in vitro O2•− scavenging activity. Finally, we evaluated the protective effect of two plant extracts (with the highest scavenging activity for O2•−) in a focal cerebral ischemia model in vivo. Results support the high antioxidant capacity of these extracts and their ability to protect neurons against oxidative stress produced during injury.
2. Materials and Methods
2.1. Materials
GlutaMAX™ (35050-061), basic fibroblast growth factor β (BFGFβ), Hoechst 33342 (H1399), (DMEM, 12800-017), neurobasal medium (21103049), and B-27 supplement (17504-044) were purchased from Thermo Fisher Scientific (Waltham, MA, USA). Poly-L-lysine (P1524), cytosine-β-D-arabino furanoside (C1768), L-glutamate (G2834), glycine (D8898), 3-(4, 5-dimethylthiazol-2-y)-2, 5-diphenyltetrazolium bromide tetrazolium salt (MTT, M5655), dihydroethidium (DHE, D7008), and resveratrol (RSV, R5010) were from Sigma-Aldrich (St. Louis, MO, USA). Gentamycin and isoflurane were from PiSA Laboratories (CDMX, Mexico). Dimethyl sulfoxide (DMSO, 07001) was from Fermont (Monterrey, NL, Mexico). Primary antibody anti-Microtubule-Associated Protein 2 (MAP-2, AB5392) was from Abcam (Cambridge, UK). The secondary antibody Alexa Fluor® 594-conjugated anti-chicken IgG (703-585-155) was from Jackson ImmunoResearch Laboratories Inc. (West Grove, PA, USA). 2, 3, 5-triphenyltetrazolium chloride (TTC, 22631) was from USB Corporation (Cleveland, OH, USA).
2.2. Plant Material
A list of nine plants used in traditional Mexican medicine was elaborated based on the information obtained through data-bank [
28]. The plants were obtained from the field in six different states of the country: Mexico City, State of Mexico, Guerrero, Chihuahua, Chiapas, and Veracruz. Reference vouchers of the plant material were deposited at the Instituto Mexicano del Seguro Social (IMSS) herbarium (IMSSM). Plant species, botanical name, family, voucher specimens, and plant parts used to obtain the extracts are summarized in
Table 1.
2.3. Preparation of the Plant Extracts
For each part of the plant, the ethanol extract was prepared by macerating 20 g of powdered dry plant material in stoppered flasks containing 300 mL of ethanol for 1 week (twice) at room temperature. After filtration, the solvent was evaporated under reduced pressure in a rotary evaporator. The different extracts were conserved in tightly sealed glass vials. The yields are shown in
Table 1.
2.4. OH• Scavenging Assay
To measure the antioxidant capacity of the extracts, OH• was generated by the reaction between Fe³⁺–ethylenediamine tetraacetic acid (EDTA) and hydrogen-peroxide (H₂O₂). The generation of the radical was assessed using terephtalic acid (TA) since the non-fluorescent compound TA reacts with OH• to form fluorescent 2-hydroxy-TA [
29]. The reaction was a mix of the following compounds in 160 µL: 0.2 mM ascorbic acid, 0.2 mM FeCl
3, 0.208 mM EDTA, and 1.4 mM TA in 20 mM phosphate buffer (pH 7.4), and were mixed with 20 μL of distilled water (0% scavenging tube) or with 20 μL of the different concentrations of samples. The reaction started with the addition of 1 mM H₂O₂ (20 μL). The fluorescence signal was measured for 30 min at a wavelength of excitation of 326 nm and emission of 432 nm in a Synergy™ HT Multi-Mode Microplate Reader (BioTek Instruments, Inc., Winooski, VT, USA). The OH• scavenging abilities were interpolated to obtain the 50% inhibitory concentrations (IC
50). RSV was used as standard OH• scavenger.
2.5. ROO• Scavenging Assay
The assays were based on the Oxygen Radical Absorbance Capacity (ORAC) test [
30], which is a method that measures the antioxidant capacity of a substance. The ORAC assay measures a fluorescent signal from a probe that is quenched in the presence of reactive oxygen species (ROS). The addition of an antioxidant absorbs the generated ROS, allowing the fluorescent signal to persist. We use 2, 2’-Azobis (2-methylpropionamidine) dihydrochloride (AAPH), a water-soluble azo compound, as a ROO• generator; Trolox
® (6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid, St. Louis, MO, USA), a water-soluble vitamin E analog and a well-known antioxidant, was used as the standard; and fluorescein as a fluorescent probe. The ORAC test produces a ROO• free radical upon thermal decomposition. This assay depends on the peroxyl radical damage to fluorescein molecules that results in a loss of fluorescence and when an antioxidant is present its antioxidant capacity correlates to the fluorescence decay curve, which is usually represented as the area under the curve. Briefly, the assay was carried out as follows: 25 μL of water, Trolox
® as the standard, or diluted samples or diluted vehicles were mixed with 25 μL of 153 mM AAPH and with 150 μL of 50 nM fluorescein and incubated at 37 °C. The fluorescence was measured every minute for 90 min using fluorescence filters for an excitation wavelength of 485 nm and an emission wavelength of 520 nm.
2.6. O₂•− Scavenging Assay
The xanthine–xanthine oxidase (XO) system was used to generate O
2•
− [
31]. This enzymatic system is useful to test for O
2•
− scavenging capacity. XO catalyzed the oxidation of hypoxanthine to xanthine and subsequently to uric acid. During the re-oxidation of XO, molecular oxygen acts as an electron acceptor. During these reactions, O
2•
− radicals are formed. To avoid false positives, it was necessary to prove that the sample does not inhibit XO activity by measuring uric acid production. O
2•
− generation and XO activity were measured as nitroblue tetrazolium (NBT) reduction and uric acid production, respectively. The assay was made as follows: 160 μL of the following reaction mixture (90 μM xanthine, 16 mM Na
2CO
3, 22.8 μM NBT, and 18 mM phosphate buffer (pH 7.0)) were mixed with 20 μL of distilled water (0% scavenging tube) or with 20 μL of different concentrations of the samples. The reaction was initiated by the addition of 20 μL of xanthine oxidase (168 U/L). Optical density was registered both at 295 nm (for uric acid production) and at 560 nm (for O
2•
− generation). RSV was used as standard O
2•
− scavenger.
2.7. Experimental Design
Ischemic damage was induced with the middle cerebral artery occlusion (MCAO) model in rats. Rats were randomly distributed in 3 groups (n = 10): CT, sham animals, subjected to surgical procedure without induced ischemia; +Vh, ischemic rats plus vehicle; and +Sp, ischemic rats plus Sp treatment. Neuronal primary cultures of the Wistar rat brain cortex were used to analyze the effect of plant extract and RSV on cellular damage. Cultures were exposed to excitotoxicity (10 min), followed by 30 min, 2 h, or 24 h of recovery (change of medium). Cultures were divided into 2 main groups (n = 4): (1) CT, cells to which the culture medium was changed by Krebs–Henseleit (KHB) solution followed by recovery; and (2) Glu, cells exposed to excitotoxicity followed by recovery. Treatments were added to the cells during the recuperation.
2.8. Treatment with Plant Extracts
All stock plant extracts were dissolved in dimethyl sulfoxide (DMSO) at 1 mg/mL. In vitro excitotoxicity model: plant extracts (0.00001 to 1 μg/μL) dissolved in DMEM-B27 were added to cell cultures after excitotoxicity treatment and were maintained during the recuperation period (24 h). The final concentration of DMSO during the treatment was 0.1%. RSV (dissolved in 0.1% ethanol) and was used in a concentration range from 0.004 to 400 µM. In vivo ischemia model: animals were injected at the onset of reperfusion in the tail vein with 100 μL of either plant extract (3 mg/kg) or vehicle (50% ethanol in double-distilled H₂O). The dose was chosen according to previous experiments with plant extracts with protective effects.
2.9. Oxidative Stress in Primary Neuronal Cultures Induced by Excitotoxicity
Primary cortical neuronal cultures were prepared as described previously [
32] with some modifications. The cerebral cortex was obtained from 18-day-old Wistar rat embryos. Cells were plated on poly-L-lysine coated plates seeded at 25 × 10
3 cells/cm
2 for immunofluorescence experiments and 50 × 10
3 cells/cm
2 for the cytotoxicity experiments and maintained at 37 °C in a humidified atmosphere of 5% CO
2/95% air on Neurobasal medium supplement with B-27 1X, serum-free, GlutaMAX™ 1X, 5 ng/mL of basic fibroblast growth factor β, and 1.26 mg/mL of gentamicin. On Day 4, a change of 50% of the medium was performed adding 4 μM cytosine-β-D-arabino furanoside (AraC) to inhibit glial growth. Neuronal cultures were used 8 days after being seeded. Excitotoxicity was induced by treatment with 100 µM
L-glutamate and 10 µM glycine for 10 min.
2.10. Determination of Cytotoxicity
Cytotoxicity was tested using the 3-(4, 5-dimethylthiazol-2-y)-2, 5-diphenyltetrazolium bromide tetrazolium (MTT) assay. After 24 h of treatment with the extract, the medium was recollected and the cultures were incubated with 0.5 mg/mL of MTT solution (37 °C, 4 h in the darkness). Formazan crystals were solubilized adding 100 µL of DMSO. Absorbance was measured at 570 and 690 nm. Results were expressed as the percent MTT reduction relative to the control.
2.11. Immunofluorescence to Identify Neurons
Cells were fixed with 0.5% formaldehyde and permeabilized with methanol. Nuclei were stained with 10 μg/mL Hoechst 33342 and an anti-MAP-2 antibody, followed by Alexa Fluor® 594-conjugated anti-chicken IgG used to identify neurons (1:10,000) by fluorescence microscopy (20X dry objective, with an Olympus model 1 × 71 microscope (Olympus Corporation of the Americas, Center Valley, PA, USA). Immuno-stained assays for glial fibrillary acidic protein revealed that the presence of astrocytes in neuronal cultures was <98%.
2.12. Measurement of Intracellular O₂•− Production Induced by Excitotoxicity
Cells were stimulated for 30 min (during recovery) with the extract (0.01 μg/μL Sp, 0.001 μg/μL GmPA, and 0.0001 μg/μL GnPA and Sa). After, cells were incubated with 0.02 mmol/L dihydroethidium dye (37 °C, 2 h in the darkness). The fluorescence of complex ethidium-DNA was measured at an excitation wavelength of 480 nm and an emission wavelength of 610nm. To normalize the fluorescence intensity, the total amount of protein was measured with the bicinchoninic acid assay.
2.13. Induction of Cerebral Ischemia with the Middle Cerebral Artery Occlusion (MCAO) Model
Handling of animals was executed under the internal protocol approved by the Institutional Animal Care and Use Committee of the Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suárez” and in accordance to the NIH Guide for the Care and Use of Laboratory Animals according to NOM-062-200 and the World Medical Association Declaration of Helsinki for the animal use in biomedical research. Transient focal cerebral ischemia was induced with the MCAO method previously described [
33]. Briefly, male Wistar rats (280–350 g) were anesthetized with a mixture of 2% oxygen and 2.5% isoflurane and then maintained at 37 °C. The surgical procedure consisted of blocking cerebral blood flow into the MCA territory by introducing a nylon monofilament suture 3-0 into the left internal carotid artery. After 2 h occlusion, animals were newly anesthetized, and the filament was removed to allow the restoration of the MCA blood flow (reperfusion). The neurological deficit was evaluated during MCAO with two behavioral tests: rats that fail to extend the right forepaw fully and accomplish turning to the left (≥5 rounds/1 min) were included in the protocol. Reperfusion was allowed for 24 h; then animals were sacrificed.
2.14. Quantification of Tissue Damage, Neurological Outcome, and Survival after MCAO
Injury-induced by ischemia was measured using the TTC salt staining. Rats were sacrificed after 2 h MCAO and 24 h reperfusion. Then, brains were removed and frozen (5 min, −80 °C). Serial coronal slides (2.5 mm width) were obtained and stained with 2% TTC in the darkness for 30 min at 37 °C and after were placed in 4% paraformaldehyde for 1 h. Finally, the slices were photographed with a digital camera (PowerShot S100, Canon, Japan). The percentage of the damage (infarct area) was calculated considering the total cerebral area obtained from the sum of all slices, which was considered as 100%. Image analysis was performed using Image J software [
34].
The “limb-use asymmetry test” was performed 24 h after MCAO to evaluate the neurological impairment of animals. Rats were placed in a transparent acrylic cylinder, and a video was recorded in the afternoon for 5 min. Locomotor asymmetry was evaluated by a test that counts the contacts that animals make with their extremities on a cylinder wall [
35]. The global use score of extremities (BIAS) was calculated by subtracting the percentage of contacts of the altered to the percentage of the not altered limb. To evaluate survival, the percentage of animals that survive 24 h relative to the total number of individuals in each group was obtained (
n = 11).
2.15. Statistical Analysis
Differences between groups were analyzed by the Student’s t-test and one-way analysis of variance (ANOVA) with a Tukey’s test. A p < 0.05 was considered statistically significant. Statistical analysis was performed using GraphPad Prism 7 (GraphPad Software, San Diego, CA, USA).
4. Discussion
Currently, phytochemicals are considered a promising strategy to protect cells from oxidative damage, historically because products of plant origin are essential sources of antioxidants and furthermore have low toxicity. Antioxidant therapy might prevent damage induced by free radicals in diseases that cause brain dysfunction, although definitive conclusions have not been obtained in the clinical area [
36]. In the present work, we first established the free radical-scavenging activity of extracts obtained from Annonaceae, Lamiaceae, and Geraniaceae plants and assessed their effect on neuronal excitotoxicity. The antioxidant capacities of the extracts were examined with three assays: the OH• scavenging activity using the Fenton reaction, ROO• scavenging activity based on the ORAC test, and O
2•
− scavenging activity by employing the xanthine–xanthine oxidase system. We selected RSV as the standard scavenger for these free radicals because RSV has a high protective effect against the cerebral ischemia-induced damage that has been associated with its electron donor properties for neutralizing free radicals [
37,
38] Additionally, RSV has very low toxicity [
10]; however, we found that RSV 400 μM was toxic for neuronal cultures. This effect can be justified because a high concentration of RSV can exhibit pro-oxidant properties, leading to oxidative breakage of cellular DNA in the presence of transition metal ions, such as copper, and increase cellular death [
39]. Such a pro-oxidant action also could be a common mechanism for anticancer and chemopreventive properties observed for some plant polyphenols [
40].
RSV is excellent antioxidant, even though an unselective OH• scavenger [
41] and all our compounds were tested against it. In our study, all the extracts tested exposed a significant OH• scavenging activity with an IC
50 ranging from 98.96 to 154.18 μg/mL, superior to that exhibited by RSV with an IC
50 of 30.02 μg/mL. The Amu (
Annona muricata) extract obtained from the leaf showed the most significant activity, possibly linked to its high content of alkaloids, flavonoids, and polyphenols, which are specifically concentrated in the fruit pulp and leaf, the main storage sites of the plant [
42]. The Ach (
Annona cherimola) extract, also obtained from the leaves, showed an IC
50 = 155.04 μg/mL, which might also be associated with its content of phenolic compounds [
42]. Regardless of the family to which the other extracts belong, any appreciable difference among their ability to quench OH• was observed. Because neuronal mitochondria generate large amounts of OH•, the extracts with high activity to quench OH• could be a marker for its application in brain protection [
43].
We also measured the ROO• scavenging activity because of its role in the chain-propagation mechanism of lipid peroxidation and its capacity to diffuse to remote cellular loci. RSV acts as an efficient ROO• scavenger (IC
50 = 0.23 ± 0.06). The values of the extracts ranged from 4.48 ± 0.24 for Ap to 102.43 ± 42.92 for Ach. These results show that the ROO• scavenging activity of the extracts is lower compared to our reference compound (RSV). We observed that Amu showed the highest scavenging activity for OH• and a modest effect on ROO•, in agreement with previous records that show the potent in vitro antioxidant capacity of this extract [
44].
Oxidative stress in stroke starts with the formation of the O
2•
−, which is produced in mitochondria as a result of the one-electron reduction of oxygen, but several additional enzymatic reactions carried by NADPH oxidases, xanthine oxidase, and others are also activated [
1]; importantly, its production is enhanced during reperfusion [
17]. Thus, counteracting O
2•
− production with the plant extracts might possess an invaluable power against ischemia-induced damage. With respect to O
2•
− scavenging activity, similar IC
50 values were observed for the extracts from Geraniaceae, followed by those from Lamiaceae. In accord, different extracts of
Geranium species show dose-dependent O
2•
− scavenging activities, whose values are very close to those observed for quercetin. Quercetin is a flavonoid with a potent antioxidant activity [
45]. Extracts of
Geranium species have a high content of phenolic compounds; the total flavonoid content varied from 7.7 to 116.5 quercetin equivalents (mg/g), and its free radical scavenging activity may come from the presence of gallic acid derivatives [
21]. Likewise, the main groups of active constituents in the Lamiaceae
Salvia spp. are more than 20 phenolic acids and flavonoids, whose antioxidant effects include anti-lipid peroxidation and free radical scavenging. Their capacity to scavenge O
2•
− is variable and depends on its specific flavonoids content [
21]. Therefore, the antioxidant properties of the compounds present in the extracts might explain their O
2•
− scavenging activities.
On the other hand, the Annona extracts (Amu, Ad, Are, and Ach, with the exception of Ap) showed a very low O
2•
− scavenging activity. Previous studies showed good but variable activity of both the methanol extract and water fraction of
Annona extracts [
42,
46,
47]. Of the 39 wild edible fruits consumed in Panama, Amu exhibited one the highest antioxidant capacity (928.57 mg Trolox
® equivalents/100 g fresh weight) with a high phenolic content while Ap (
Annona purpurea) presented the lowest antioxidant activity (16.22 mg Trolox
® equivalents/100 g fresh weight) with a low phenolic content [
48]. The species but also the processing of the plant and the method of quantification might explain the discrepancies found with our study.
In fact, the extraction method used in this work was the maceration of powdered dry plant material in ethanol; the macerate was left for one week, and after filtration and evaporation, the extracts were obtained. This extraction procedure is the most commonly used due to its simplicity; however, the extraction time is extensive, and the yield is low [
49]. Perhaps changing the extraction method would provide extracts that showed more significant effects on the measured parameters. Nonetheless, it is clear that the effects of the extracts were substantial.
On the other hand, it has been reported that, compared with other antioxidants, O
2•
− scavenging activity of RSV is high [
38,
50,
51], However, using the xanthine–xanthine oxidase system, we observed that the antioxidant effect of RSV is related to the inhibition of the production of O
2•
− and, furthermore, to its neutralization. Therefore, we could not compare the activity of the extracts with RSV. Thus, to achieve a proper comparison with RSV, the analysis of purified components of each extract must be performed.
4.1. Extracts Prevent Oxidative Stress Induced by Excitotoxicity in Cultured Neurons
Glutamate is the principal excitatory neurotransmitter in mammalian cells, and its excessive liberation during stroke initiates a process called excitotoxicity. Overstimulation of the glutamate N-methyl-D-aspartate type receptor results in cell death. The injury is associated with failing calcium extrusion from the cell. When calcium is accumulated in the mitochondria causes cellular damage, which has been related to oxidative stress [
1]. To evaluate if the extracts have an intracellular antioxidant effect, we used an in vitro model of excitotoxicity. We found that all the extracts have cytotoxic effects at the concentration of 1 μg/mL. In contrast, when lower concentrations were used, the extracts showed different effects, which varied according to the family of the plants.
The higher concentrations of extracts from the Annonacea family showed a cytotoxic effect, a response that could be associated with the previously described anti-cancer effect of some species of this family [
52]. The Ach extract was the most lethal with a concentration-dependent cytotoxic effect, followed by Are and Amu extracts, which have a high level of toxicity from 0.1 μg/mL. Previous studies using methanol and water fractions of the Are showed growth inhibition using 250 μg/mL in human hepatocellular carcinoma HepG2 cells, but lower doses (50–200 μg/mL) have a protective effect [
53]. These data suggest that neuronal cultures have a high sensibility to components of the extract. In agreement, the Annonaceae family (Amu and
A. squamosa) contain neurotoxic benzyltetrahydro-isoquinoline alkaloids that could be a central etiological factor to induce Parkinsonism [
53] The development of neurodegenerative disease also has been related to the consumption of annonaceous acetogenins. The prototypical acetogenins annonacin decreased brain ATP levels by 44%, causing neuropathological abnormalities including the loss of neurons accompanied by a significant proliferation of astrocytes and microglial cells [
53].
On the other hand, we found that extracts from Lamiaceiae and Geraniaceae plants have a protective effect at concentrations fluctuating from 0.01 to 0.1 μg/mL. In agreement, different ethanol extracts from
Geranium species showed dose-dependent but negligible cytotoxicity in the concentration range of 0.1–10 μg/mL; although, water extracts of two species (
G. psilostemon and
G. stepporum) showed cytotoxicity at 10 μg/mL [
21,
54]. Specifically,
G. mexicanum has a high content of (+)-catenin and (−) epicatechin, compounds that have shown neuroprotective effects in ischemia models [
21,
22]. Catechin can improve mitochondrial function and relieve apoptosis through promoting activation of AKT cell signaling [
23], suggesting a mechanism that might prevent neuronal death.
Salvia species contain phytochemicals as terpenoids, diterpenoids, and phenolic acids with pharmacological activities for the treatment of cardiovascular, immune, hepatic, and renal diseases [
55] Likewise, components of
Salvia mitiorrhiza, such as polyphenols, tanshinones, and phenolics, protect against brain disease [
56]. These results indicate that the extracts with the highest level of protection against free radical species but with the lowest level of cytotoxicity to neurons could be good candidates for the treatment of diseases associated with oxidative stress in the brain.
4.2. Sp Extract Protects against Cerebral Ischemia-Induced Damage
MCAO in the rat is the ischemic model that better simulates stroke in humans. In cerebral ischemia, O
2•
− is the principal free radical produced and is associated with damage after reperfusion [
16]. Therefore, we first tested the effect of GmPA, GnPA, Sa, and Sp on the intracellular production of O
2•
− induced by glutamate exposition. As could be expected, all extracts reduced O
2•
− production. However, when we tested the extracts in the in vivo model of cerebral ischemia, we observed that while Sp reduced the damage induced by reperfusion, GmPA was excessively toxic to animals. The drastic difference in the effect observed for both extracts could be associated with specific properties of individual components. Although, some components of the extracts have been isolated, and additional studies are thus necessary [
21].
We postulated that compounds present on Sp extract, besides lowering the stress oxidative-induced damage, might allow adaptations on gene regulation. For example, aerial parts of Sp contain eleven neo-cleorodane difepenoids; some of these compounds augmented the expression of extracellular matrix components (e.g., genes codifying type I, II, and V collagens and elastin) [
57], which are critical for vascular basement membrane function and play a central role in cerebrovascular diseases [
58]. Compounds in
S. mitiorrhiza can also inhibit the expression of adhesion molecules in vascular endothelium and in leukocytes that help to prevent the development of vascular damage induced by ischemia and reperfusion [
59]. Additionally, clerodane dipertenos have been isolated from different
Salvia species. Clerodane dipertenos activate opioid receptors [
60]. The main active constituent isolated from the leaves of
S. divinorum is the neoclerodane diterpene salvinorin A, which has shown reduced infarct volume and improved neurological deficits. It also reduced Evans blue extravasation, suggesting reduced impairment of the blood-brain barrier, and decreased the expression of cleaved casepase-3, IL-10, and TNF-alpha in the penumbral areas, preventing apoptosis and reducing inflammation [
27]. Thus, our results suggest that extracts from Lamiaceae could be an alternative for treating cerebral ischemia, but it will be necessary to characterize the components of the extract; that is, the identification and evaluation of the active compounds will be required to elucidate its mechanism of action in the induced protection against cerebral ischemia